KemPharm
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KemPharm and buy or sell other stocks, ETFs, and their options commission-free!About KMPH
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia.
CEONeil F. McFarlane
CEONeil F. McFarlane
Employees59
Employees59
HeadquartersCelebration, Florida
HeadquartersCelebration, Florida
Founded2006
Founded2006
Employees59
Employees59
KMPH Key Statistics
Market cap495.28M
Market cap495.28M
Price-Earnings ratio14.20
Price-Earnings ratio14.20
Dividend yield—
Dividend yield—
Average volume941.99K
Average volume941.99K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.16
52 Week high$13.16
52 Week low$6.19
52 Week low$6.19
Stock Snapshot
KemPharm(KMPH) stock is priced at $8.81, giving the company a market capitalization of 495.28M. It carries a P/E multiple of 14.20.
On 2026-01-02, KemPharm(KMPH) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for KemPharm(KMPH) stock has reached 0, versus its average volume of 941.99K.
The stock's 52-week range extends from a low of $6.19 to a high of $13.16.
The stock's 52-week range extends from a low of $6.19 to a high of $13.16.
People also own
Based on the portfolios of people who own KMPH. This list is generated using Robinhood data, and it’s not a recommendation.